This topic contains a solution. Click here to go to the answer

Author Question: What was the cause of death among neonates treated with an oxygenator constructed of ... (Read 31 times)

roselinechinyere27m

  • Hero Member
  • *****
  • Posts: 557
What was the cause of death among neonates treated with an oxygenator constructed of dimethylpolysiloxan e used in a 1963 ECLS trial?
 
  A. pulmonary embolismB. intraventricular hemorrhage
  C. infant respiratory distress syndrome
  D. bronchopulmonary dysplasia

Question 2

Which of the following factors are included as general guidelines for neonatal ECLS? I. a disease process deemed reversible II. gestational age older than 24 weeks III. body weight greater than 2 kg IV. absence of intraventricular hemorrhage
 
  A. I, IV only
  B. II, III only
  C. I, III, IV only
  D. II, III, IV only



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

leannegxo

  • Sr. Member
  • ****
  • Posts: 374
Answer to Question 1

ANS: B
A. Incorrect response: See explanation B.
B. Correct response: An oxygenator constructed of a membrane composed of dimethylpolysiloxan e, similar to the one currently in common use, was developed in 1963. Several neonates were supported with ECLS, but all died of intraventricular hemorrhage.
C. Incorrect response: See explanation B.
D. Incorrect response: See explanation B.

Answer to Question 2

ANS: C
A. Incorrect response: See explanation C.
B. Incorrect response: See explanation C.
C. Correct response: The general guidelines for neonatal ECLS include (1) a disease process that is deemed reversible, (2) gestational age greater than 32 weeks, (3) weight greater than 2 kg, (4) significant mechanical ventilation for no more than 7 to 10 days before ECLS, (5) absence of intraventricular hemorrhage, (6) no severe neurologic dysfunction, and (7) no significant chromosomal abnormality.
D. Incorrect response: See explanation C.




roselinechinyere27m

  • Member
  • Posts: 557
Reply 2 on: Jul 16, 2018
YES! Correct, THANKS for helping me on my review


JCABRERA33

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

For a complete list of videos, visit our video library